Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Testosterone Gel 1.62% vs AndroGel in Hypogonadal Men
NCT02110368Phase 3Completed
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Amneal Pharmaceuticals, Inc.. Started Mar 2014; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02110368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02110368.